These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 25944689)
41. Docetaxel-ifosfamide combination in patients with advanced breast cancer failing prior anthracycline-based regimens: results of a phase I-II study. Kosmas C; Tsavaris N; Mylonakis N; Tsakonas G; Gassiamis A; Skopelitis H; Polyzos A; Malamos N; Karabelis A J Chemother; 2007 Jun; 19(3):322-31. PubMed ID: 17594929 [TBL] [Abstract][Full Text] [Related]
42. Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer. Comella P; Massidda B; Palmeri S; Putzu C; De Rosa V; Izzo F; Fiore F; Casaretti R; Sandomenico C Anticancer Drugs; 2006 Sep; 17(8):985-92. PubMed ID: 16940809 [TBL] [Abstract][Full Text] [Related]
43. A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes. Campone M; Isambert N; Bourbouloux E; Roché H; Bonneterre J; Milano G; Fumoleau P Cancer Chemother Pharmacol; 2012 Apr; 69(4):871-9. PubMed ID: 22045498 [TBL] [Abstract][Full Text] [Related]
44. Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer. Kouroussis C; Androulakis N; Kakolyris S; Souglakos J; Kotsakis T; Mavroudis D; Katsogridakis K; Vardakis N; Hatzidaki D; Samonis G; Vlachonikolis J; Georgoulias V J Clin Oncol; 1999 Mar; 17(3):862-9. PubMed ID: 10071277 [TBL] [Abstract][Full Text] [Related]
45. A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. Karachaliou N; Ziras N; Syrigos K; Tryfonidis K; Papadimitraki E; Kontopodis E; Bozionelou V; Kalykaki A; Georgoulias V; Mavroudis D Cancer Chemother Pharmacol; 2012 Jul; 70(1):169-76. PubMed ID: 22669571 [TBL] [Abstract][Full Text] [Related]
46. Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity. Montagna E; Cancello G; Bagnardi V; Pastrello D; Dellapasqua S; Perri G; Viale G; Veronesi P; Luini A; Intra M; Calleri A; Rampinelli C; Goldhirsch A; Bertolini F; Colleoni M Clin Breast Cancer; 2012 Jun; 12(3):207-14. PubMed ID: 22520733 [TBL] [Abstract][Full Text] [Related]
47. Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer. Oshita F; Yamada K; Kato Y; Ikehara M; Noda K; Tanaka G; Nomura I; Suzuki R; Saito H Cancer Chemother Pharmacol; 2003 Jul; 52(1):73-8. PubMed ID: 12750839 [TBL] [Abstract][Full Text] [Related]
48. A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma. Kim YS; Lee SI; Park SH; Park S; Hwang IG; Lee SC; Sun JM; Lee J; Lim HY Clin Genitourin Cancer; 2016 Feb; 14(1):76-81. PubMed ID: 26454620 [TBL] [Abstract][Full Text] [Related]
49. Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. Choi HJ; Cho BC; Shin SJ; Cheon SH; Jung JY; Chang J; Kim SK; Sohn JH; Kim JH Cancer Chemother Pharmacol; 2008 Feb; 61(2):309-13. PubMed ID: 17576560 [TBL] [Abstract][Full Text] [Related]
50. Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX. Mazard T; Ychou M; Thezenas S; Poujol S; Pinguet F; Thirion A; Bleuse JP; Portales F; Samalin E; Assenat E Cancer Chemother Pharmacol; 2012 Mar; 69(3):807-14. PubMed ID: 22037922 [TBL] [Abstract][Full Text] [Related]
51. Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study. Rau KM; Lin YC; Chen YY; Chen JS; Lee KD; Wang CH; Chang HK BMC Cancer; 2015 May; 15():423. PubMed ID: 25994543 [TBL] [Abstract][Full Text] [Related]
52. A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy. Saif MW; Kaley K; Brennan M; Garcon MC; Rodriguez G; Rodriguez T JOP; 2013 Sep; 14(5):498-501. PubMed ID: 24018594 [TBL] [Abstract][Full Text] [Related]
53. Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Barnard RA; Wittenburg LA; Amaravadi RK; Gustafson DL; Thorburn A; Thamm DH Autophagy; 2014 Aug; 10(8):1415-25. PubMed ID: 24991836 [TBL] [Abstract][Full Text] [Related]
54. Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer. Mani S; Rudin CM; Kunkel K; Holmlund JT; Geary RS; Kindler HL; Dorr FA; Ratain MJ Clin Cancer Res; 2002 Apr; 8(4):1042-8. PubMed ID: 11948111 [TBL] [Abstract][Full Text] [Related]
55. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial. Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kourousis C; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V Dig Dis; 2007; 25(1):100-5. PubMed ID: 17384515 [TBL] [Abstract][Full Text] [Related]
57. Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma. Twu CW; Lin PJ; Tsou HH; Liu YC; Jiang RS; Liang KL; Lin TY; Wang WY; Lin JC Head Neck; 2022 Jun; 44(6):1453-1461. PubMed ID: 35362634 [TBL] [Abstract][Full Text] [Related]
58. Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors. Chude CI; Amaravadi RK Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621712 [TBL] [Abstract][Full Text] [Related]
59. Outcome of early clinical trials of the combination of hydroxychloroquine with chemotherapy in cancer. Poklepovic A; Gewirtz DA Autophagy; 2014 Aug; 10(8):1478-80. PubMed ID: 24991829 [TBL] [Abstract][Full Text] [Related]
60. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors. Spugnini EP; Buglioni S; Carocci F; Francesco M; Vincenzi B; Fanciulli M; Fais S J Transl Med; 2014 Aug; 12():225. PubMed ID: 25143012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]